BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14969737)

  • 1. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
    Mueller HT; Haroutunian V; Davis KL; Meador-Woodruff JH
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):60-9. PubMed ID: 14969737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons.
    Okada H; Matsushita N; Kobayashi K; Kobayashi K
    J Neurochem; 2004 Apr; 89(1):7-14. PubMed ID: 15030384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder.
    Clinton SM; Meador-Woodruff JH
    Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.
    Clinton SM; Haroutunian V; Davis KL; Meador-Woodruff JH
    Am J Psychiatry; 2003 Jun; 160(6):1100-9. PubMed ID: 12777268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential co-localization of neurokinin-3 receptor and NMDA/AMPA receptor subunits in neurons of the substantia nigra of C57/BL mice.
    Wang YQ; Hu HJ; Cao R; Chen LW
    Brain Res; 2005 Aug; 1053(1-2):207-12. PubMed ID: 16038885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system.
    Ortiz J; Fitzgerald LW; Charlton M; Lane S; Trevisan L; Guitart X; Shoemaker W; Duman RS; Nestler EJ
    Synapse; 1995 Dec; 21(4):289-98. PubMed ID: 8869159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
    Clinton SM; Haroutunian V; Meador-Woodruff JH
    J Neurochem; 2006 Aug; 98(4):1114-25. PubMed ID: 16762023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evidence for localization of NMDAR1 receptor subunit on dopaminergic neurons of the rat substantia nigra, pars compacta.
    Wedzony K; Czepiel K; Fijał K
    Pol J Pharmacol; 2001; 53(6):675-9. PubMed ID: 11985345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.
    Beneyto M; Meador-Woodruff JH
    Synapse; 2006 Dec; 60(8):585-98. PubMed ID: 16983646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
    Petri S; Krampfl K; Dengler R; Bufler J; Weindl A; Arzberger T
    J Comp Neurol; 2002 Oct; 452(4):360-6. PubMed ID: 12355418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
    Kristiansen LV; Beneyto M; Haroutunian V; Meador-Woodruff JH
    Mol Psychiatry; 2006 Aug; 11(8):737-47, 705. PubMed ID: 16702973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
    Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
    J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of genes encoding glutamate receptors and transporters in rod and cone bipolar cells of the primate retina determined by single-cell polymerase chain reaction.
    Hanna MC; Calkins DJ
    Mol Vis; 2007 Nov; 13():2194-208. PubMed ID: 18087239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans.
    Zheng Y; Watakabe A; Takada M; Kakita A; Namba H; Takahashi H; Yamamori T; Nawa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):701-6. PubMed ID: 19336245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.
    Counihan TJ; Landwehrmeyer GB; Standaert DG; Kosinski CM; Scherzer CR; Daggett LP; Veliçelebi G; Young AB; Penney JB
    J Comp Neurol; 1998 Jan; 390(1):91-101. PubMed ID: 9456178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for the presence of glucocorticoid receptors in dopaminergic neurons of rat ventral tegmental area and substantia nigra.
    Czyrak A; Chocyk A
    Pol J Pharmacol; 2001; 53(6):681-4. PubMed ID: 11985346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
    Beneyto M; Kristiansen LV; Oni-Orisan A; McCullumsmith RE; Meador-Woodruff JH
    Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.